Tapering group | Usual care group | |||
---|---|---|---|---|
β | 95% CI | β | 95% CI | |
MTW-DAS28-CRP | 0.64 | 0.14 to 1.14 | 0.17 | −0.29 to 0.62 |
Constant | −0.73 | −0.20 | ||
MTW-TJ | 0.24 | 0.07 to 0.10 | 0.05 | −0.13 to 0.24 |
MTW-SJ | 0.65 | 0.25 to 1.04 | 0.21 | −0.19 to 0.62 |
MTW-PG-VAS | 0.02 | −0.0001 to 0.38 | 0.004 | −0.02 to 0.03 |
MTW-CRP | −0.001 | −0.05 to 0.05 | 0.006 | −0.03 to 0.05 |
Occurrence of flare | 0.24 | −0.38 to 0.87 | 0.091 | −0.57–0.75 |
Constant | 0.58 | 0.13 | ||
Number of flare per patient | −0.025 | −0.34 to 0.29 | 0.041 | −0.36 to 0.44 |
Constant | 0.78 | 0.14 | ||
Occurrence of major flare | 0.69 | −0.16 to 1.53 | 0.82 | −0.86 to 1.08 |
Constant | 0.67 | 0.14 | ||
Number of major flare per patient | 0.71 | −0.06 to 1.47 | 0.11 | −0.86 to 1.08 |
Constant | 0.66 | 0.14 | ||
TNFi use (% ddd) | 0.43 | −0.65 to 1.51 | −0.068 | −1.38 to 1.25 |
Constant | 0.54 | 0.21 |
%ddd, percentage of the defined daily dose; CRP, C reactive protein; MTW-DAS28-CRP, mean time-weighted DAS28-CRP; PG-VAS, patient global visual analogue scale; SJ, swollen joint count; TJ, tender joint count.